Abbott Laboratories (ABT)

Exchange: New York Stock Exchange
Currency: USD

 
Price: 108.64 (Close)

Summary

 

52 Week range 200d Moving Avg. Beta
61.61 – 114.20 91.59 0.89
Dividend Dividend Yield Ex-Dividend date
1.40 1.29% 2020-07-14
P/E Ratio Latest EPS DGR 3 years
62.01 1.33 7.17%
Overvalued
Low
Average Volatility
High
Slow
Dividend Growth
Fast

Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

 

Sector: Industry:
Health Technology Medical Specialties
Dividend Aristocrat

Environment, Social and Governance (ESG) Ratings

Total ESG Score

33 – 61 percentile

Environment

4 – 5 percentile

Social

21 – 5 percentile

Governance

14 – 5 percentile

Controversy level

3

Peers

Dividend aristocrats in the same sector are:
– Cardinal Health Inc. (CAH)
– AbbVie Inc. (ABBV)
– Becton Dickinson (BDX)
– Medtronic plc (MDT)
– Johnson & Johnson (JNJ)


Dividend Safety Metrics

Latest EPS 1.33
Annual Payout 1.40
Payout Ratio 105.26%
Dividend growth 25 Years
Dividend Score 74
Dividend Coverage Ratio 1.24
Altman-Z score 3.81 Safe Zone

 


Estimated Future Total Return Metrics

Total return last 5Y 22.60%
Dividend growth 5Y 7.78%
Current dividend yield 1.29%
Average dividend yield last 5Y 1.94%
Estimated EPS growth next 5Y 11.50%
Extra return due to over/under valuation -7.90%
Estimated future return 5Y (CAGR) 5.50%

 

Abbott Laboratories (ABT) Valuation


Abbott Laboratories current dividend yield of 1.29% is -34% below its 5-year average. The 5-year average dividend yield is 1.94% (see red-line in chart). This indicates the stock looks overvalued today.

Abbott Laboratories (ABT) Performance

The chart below displays the total price return(%) of Abbott Laboratories for different periods:

 

Abbott Laboratories (ABT) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of Abbott Laboratories for different periods:

 


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
1.29 1.40 105.26% 25 Years

 

Dividend Growth Summary

3 Year Growth Rate (CAGR) 7.17%
5 Year Growth Rate (CAGR) 7.78%
10 Year Growth Rate (CAGR) 5.51%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2020 1.440 -%
2019 1.280 14.3%
2018 1.120 5.7%
2017 1.060 1.9%
2016 1.040 8.3%
2015 0.960 9.1%
2014 0.880 57.1%
2013 0.560 -41.9%
2012 0.964 6.9%
2011 0.902 9.3%
2010 0.825 10.3%
2009 0.748 11.0%
2008 0.674 10.6%
2007 0.609 9.5%
2006 0.557 6.9%
2005 0.521 9.3%

Abbott Laboratories (ABT) Dividend Payment History